Mexico Upstream Bioprocessing Market Size & Outlook

The upstream bioprocessing market in Mexico is expected to reach a projected revenue of US$ 542.5 million by 2030. A compound annual growth rate of 14.5% is expected of Mexico upstream bioprocessing market from 2024 to 2030.
Revenue, 2023 (US$M)
$217.4
Forecast, 2030 (US$M)
$542.5
CAGR, 2024 - 2030
14.5%
Report Coverage
Mexico

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Mexico upstream bioprocessing market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Mexico upstream bioprocessing market highlights

  • The Mexico upstream bioprocessing market generated a revenue of USD 217.4 million in 2023 and is expected to reach USD 542.5 million by 2030.
  • The Mexico market is expected to grow at a CAGR of 14.5% from 2024 to 2030.
  • In terms of segment, bioreactors/fermenters was the largest revenue generating product in 2023.
  • Cell Culture Products is the most lucrative product segment registering the fastest growth during the forecast period.


Upstream bioprocessing market data book summary

Market revenue in 2023USD 217.4 million
Market revenue in 2030USD 542.5 million
Growth rate14.5% (CAGR from 2024 to 2030)
Largest segmentBioreactors/fermenters
Fastest growing segmentCell Culture Products
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationBioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags & Containers
Key market players worldwideThermo Fisher Scientific Inc, Merck KGaA, Corning Inc, Sartorius AG, Eppendorf, Danaher Corp, Boehringer Ingelheim, Getinge AB Class B, Lonza Group Ltd, Avantor Inc, Repligen Corp, Entegris Inc, PBS Biotech, Meissner, Kuhner Shaker


Other key industry trends

  • In terms of revenue, Mexico accounted for 0.9% of the global upstream bioprocessing market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil upstream bioprocessing market is projected to lead the regional market in terms of revenue in 2030.
  • Argentina is the fastest growing regional market in Latin America and is projected to reach USD 502.9 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Upstream Bioprocessing Market Companies

Name Profile # Employees HQ Website
Kuhner Shaker View profile 11-50 Birsfelden, Basel-Landschaft, Switzerland, Europe https://kuhner.com
PBS Biotech View profile 51-100 Camarillo, California, United States, North America http://www.pbsbiotech.com
Entegris Inc View profile 8000 129 Concord Road, Billerica, MA, United States, 01821 https://www.entegris.com
Meissner View profile 51-100 Camarillo, California, United States, North America https://www.meissner.com/
Repligen Corp View profile 1783 41 Seyon Street, Building 1, Suite 100, Waltham, MA, United States, 02453 https://www.repligen.com
Eppendorf View profile 1001-5000 Hamburg, Hamburg, Germany, Europe https://dasgip.de
Corning Inc View profile 49800 One Riverfront Plaza, Corning, NY, United States, 14831 https://www.corning.com
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
Getinge AB Class B View profile 11862 Lindholmspiren 7A, P.O. Box 8861, Gothenburg, Sweden, SE-417 56 https://www.getinge.com
Avantor Inc View profile 14500 100 Matsonford Road, Suite 200, Building One, Radnor Corporate Center, Radnor, PA, United States, 19087 https://www.avantorsciences.com
Sartorius AG View profile 14338 Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 https://www.sartorius.com
Danaher Corp View profile 63000 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 https://www.danaher.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
Lonza Group Ltd View profile 18000 Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 https://www.lonza.com
Merck KGaA View profile 62345 Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 https://www.emdgroup.com

Mexico upstream bioprocessing market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to upstream bioprocessing market will help companies and investors design strategic landscapes.


Bioreactors/fermenters was the largest segment with a revenue share of 34.59% in 2023. Horizon Databook has segmented the Mexico upstream bioprocessing market based on bioreactors/fermenters, cell culture products, filters, bioreactors accessories, bags & containers covering the revenue growth of each sub-segment from 2018 to 2030.


Mexico’s upstream bioprocessing market is expected to witness a lucrative growth rate during the forecast period. Mexico offers several competitive advantages in biopharmaceutical manufacturing. Its large population, low manufacturing costs, relatively relaxed regulatory framework, and strategic position as a hub for several U.S. companies are boosting biopharmaceutical growth in this region.

This growth further strengthens upstream bioprocesses involved during biomanufacturing. Most companies operating in Mexico’s biopharmaceutical industry involve subsidiaries of international companies, which are engaged in research or production processes. 

Some of the biopharmaceutical firms undertake partnership and agreement models to supply their products. For instance, in January 2020, Zhittya Genesis Medicine, Inc. and Regenerative Medicine of Latin America, Inc. entered into a partnership agreement to commercialize biological drugs in the territories of Mexico.

Reasons to subscribe to Mexico upstream bioprocessing market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Mexico upstream bioprocessing market databook

  • Our clientele includes a mix of upstream bioprocessing market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Mexico upstream bioprocessing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico upstream bioprocessing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Mexico upstream bioprocessing market size, by product, 2018-2030 (US$M)

Mexico Upstream Bioprocessing Market Outlook Share, 2023 & 2030 (US$M)

Mexico upstream bioprocessing market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online